Litcius/Paper detail

Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas

Qing Deng, Guangchun Han, Nahum Puebla‐Osorio, Man Chun John, Paolo Strati, Beth Chasen, Enyu Dai, Minghao Dang, Neeraj Jain, Haopeng Yang, Yuanxin Wang, Shaojun Zhang, Ruiping Wang, Runzhe Chen, Jordan Showell, Sreejoyee Ghosh, Sridevi Patchva, Qi Zhang, Ryan Sun, Frederick Hagemeister, Luis Fayad, Felipe Samaniego, Hans C. Lee, Loretta J. Nastoupil, Nathan Fowler, R. Eric Davis, Jason R. Westin, Sattva S. Neelapu, Linghua Wang, Michael R. Green

2020Nature Medicine595 citationsDOIOpen Access PDF

Topics & Concepts

CD19ToxicityMedicineB cellCellLymphomaImmunologyCancer researchInternal medicineBiologyAntibodyGeneticsCAR-T cell therapy researchIntegrated Circuits and Semiconductor Failure AnalysisAdvancements in Semiconductor Devices and Circuit Design
Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas | Litcius